Ludia Bio, UAB Spin-off to Contribute to the Development of Biosimilars
November 25, 2025
November 25, 2025
BARCELONA, Spain, Nov. 25 -- The Autonomous University of Barcelona issued the following news:
* * *
Ludia Bio, new UAB spin-off to contribute to the development of biosimilars
The UAB has created a new knowledge-based company operating from the Department of Pharmacology, Therapeutics and Toxicology and specialising in scientific advice for the development of biosimilar medicines.
The market for biosimilars, medicines that are essentially the . . .
* * *
Ludia Bio, new UAB spin-off to contribute to the development of biosimilars
The UAB has created a new knowledge-based company operating from the Department of Pharmacology, Therapeutics and Toxicology and specialising in scientific advice for the development of biosimilar medicines.
The market for biosimilars, medicines that are essentially the . . .